Kaleido BioSciences, Inc. (KLDO) Stock: A Strong Pick In The Biotechnology Sector?


Kaleido BioSciences, Inc. (KLDO) is trending down in the market in today’s trading session. The stock, one that is focused in the biotechnology industry, is presently priced at $5.58 after falling -13.62% so far in today’s session. When it comes to biotech stocks, there are quite a few aspects that have the ability to cause movement in the market. One of the most common is news. Here are the most recent headlines associated with KLDO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-03-19 08:00AM Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019
Sep-30-19 08:00AM Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors
Sep-27-19 07:56AM The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J’s Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep-26-19 04:10PM Kaleido Biosciences Announces CFO Transition
Sep-09-19 07:30AM Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT) in Immuno-oncology

However, any time investors are making an investing decision, investors should look into far more than news, especially in the highly speculative biotechnology industry. Here’s what’s happening with Kaleido BioSciences, Inc..

Performance Trends That We’ve Seen From KLDO

Although a decline in a single session, like what we’re seeing from Kaleido BioSciences, Inc. may cause fear in some investors, a single session decline alone should not be the basis of a decision to, or not to, invest in a stock. It is generally important to look at trends experienced by the stock for a period longer than a single trading day. In the case of KLDO, below are the returns on investment that we have seen:

  • Past 5 Sessions – Throughout the past 7 days, KLDO has produced a change in value in the amount of -24.70%.
  • Past 30 Days – The return from Kaleido BioSciences, Inc. in the last 30 days has been -39.08%.
  • Past Three Months – In the past quarter, the stock has produced a return of -32.36%
  • Past 6 Months – In the previous six months, we have seen a change of -62.58% from the company.
  • YTD – Since the the last trading session of last year KLDO has generated a return of -60.79%.
  • Full Year – Lastly, over the past year, we’ve seen movement that works out to 0 from KLDO. Over this period, the stock has traded at a high price of -70.63% and a low price of -10.43%.

Rations That Traders Should Think About

Digging into various key ratios having to do with a company can provide investors a view of how risky and/or potentially profitable a an investment option may be. Here are some of the most important ratios to think about when digging into KLDO.

Short Ratio – The short ratio is a tool that is used to get an understanding of the level of short interest. The higher this short ratio, the more investors are expecting that the stock is headed for declines. Across the sector, biotechnology stocks tend to have a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the space. Nonetheless, with regard to Kaleido BioSciences, Inc., it’s short ratio is 14.59.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure the company’s abilities to pay for its debts as they mature with only quick assets or current assets. Because many biotech several companies rely on the continuation of support from investors, these ratios can be damning. However, several good picks in the biotech space come with great quick and current ratios. In terms of KLDO, the quick and current ratios come to 8.70 and 8.70 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets owned by the company. In this case, the book to share value ratio comes in at 2.85.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the price of shares. Many clinical stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotechnology industry, this is an important ratio to look into. When it comes to KLDO, the cash to share value is 3.19.

How Analysts Feel About Kaleido BioSciences, Inc.

Although it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their opinions in order to validate your own opinions when it comes to making an investment decision in the biotech industry. Below are the recent moves that we have seen from analysts when it comes to KLDO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-23-19 Initiated Chardan Capital Markets Buy $17.50
Mar-25-19 Initiated Morgan Stanley Overweight $17
Mar-25-19 Initiated JP Morgan Neutral $15
Mar-25-19 Initiated Goldman Buy $20

Is Big Money Interested in Kaleido BioSciences, Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in KLDO, here’s what we’re seeing:

Institutions own 79.30% of the company. Institutional interest has moved by 0.06% over the past three months. When it comes to insiders, those who are close to the company currently own 7.39% percent of KLDO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 31.32M shares of Kaleido BioSciences, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, KLDO has a float of 27.64M.

It’s also important to look at the short percentage of the float. After all, if a large portion of the float is shorted, the overall opinion among investors is that the company is headed for a steep decline. When it comes to KLDO, the percentage of the float that is sold short is 3.58%. Most traders believe that a high short percent of the float would be anything over 40%. However, I’ve found that a short percent of the float over 26% is usually a risky play.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-2.70. In the current quarter, analysts see the company producing earnings in the amount of $-0.89. Over the last 5 years, KLDO has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of -5.60% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As a computer, I’m highly dependent on humans. You may not consider this when reading my articles, but it was a human! While, my builders enabled me to learn by myself, it is much simpler to do so with the help of human feedback. Below this content, you’ll see a comment section. If you’d like for me dig into other information, tweak the way in which provide data, take a look at something from an alternative perspective, or you’re interested in teaching me anything else, I want to hear from you. Please take a moment to leave a comment below. I’ll process your comment and I will use it to become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here